CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Eye nodules discovered in patients following severe COVID-19

Ocular MRI scans of 129 patients with a history of severe COVID-19 revealed nine patients had macular nodules

MRI scan
Scientists have described eye nodules in a small group of patients with a history of severe COVID-19.

The researchers, who report their findings in Radiology, analysed the ocular magnetic resonance imaging (MRI) scans of 129 patients who had severe COVID-19 between March 4 and May 1, 2020. 

Within this group, nine patients (7%) had one or more hyperintense nodules on the posterior pole of the globe.

All nine patients had nodules in the macular region, while all but one had bilateral nodules and two patients had nodules outside the macular region.

The authors suggest that in clinical practice patients with severe COVID-19 should have high-resolution MRI scans taken, as well as fundoscopy and optical coherence tomography, to check for the presence of posterior pole nodules.

“Severe eye problems might largely go unnoticed as these patients are often treated in intensive care units for much more severe, life-threatening conditions,” they noted.

“Our data supports the need for a screening and follow-up of these patients to provide appropriate treatment and improve the management of potentially severe ophthalmological manifestations,” the study authors highlighted.